Generate a tailored SOP for Dr. Juliana Hamzah. Improve your application with a focused, well-structured draft.
Juliana Hamzah is an Associate Professor and Cancer Council WA Research Fellow at the Harry Perkins Institute of Medical Research. With over 13 years of research experience, she specializes in developing targeted drug delivery technology platforms for imaging and treating diseases such as cancer and atherosclerosis. Juliana completed her PhD in 2005 and underwent postdoctoral training at the WA Institute of Medical Research, working under Professor Ruth Ganss to develop cancer therapies. She received a prestigious American Heart Association Postdoctoral Fellowship and gained further expertise in engineering theranostic agents at Sanford-Burnham Medical Research Institute in California. Upon returning to Perth in 2013, she established her research team at the Harry Perkins Institute. Her current research focuses on devising strategies to specifically target diseases like cancer and chronic inflammatory diseases through innovative diagnostic imaging and local therapeutic interventions. Juliana is also involved in understanding the dynamics of macrophages and the extracellular matrix in disease contexts, efficiently delivering therapeutics while minimizing off-target effects. Her work aligns with the UN Sustainable Development Goals aimed at promoting health and well-being globally.
Harry Perkins Institute of Medical Research • Perth
Head of the Laboratory for Targeted Drug Delivery and Imaging Therapy.
Requirements are standardized across the Graduate School for most Master by Coursework programs at UWA.